首页|血清AFP、CEA、CA19-9检测在中国人群肝癌机会性筛查中应用的荟萃分析

血清AFP、CEA、CA19-9检测在中国人群肝癌机会性筛查中应用的荟萃分析

扫码查看
目的 通过荟萃分析评价血清甲胎蛋白(AFP)、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)在中国人群肝癌机会性筛查中的应用价值.方法 检索中国知网、万方数据库和重庆维普数据库及PubMed、Embase、Cochrane Library从建库至2023年6月收录的AFP、CEA、CA19-9联合筛查肝癌的文献.采用诊断准确性研究的质量评价工具(QUADAS-2)对文献进行质量评价.采用Stata17.0统计软件进行荟萃分析,通过Deeks漏斗图分析文献的发表偏倚.结果 共24篇文献符合纳入排除标准,其中肝癌患者组1471例,对照组2 150例.AFP在肝癌诊断(筛查)中总灵敏度为0.71(95%CI:0.66~0.75),总特异度为0.86(95%CI:0.80~0.90),综合受试者工作特征曲线(sROC)曲线下面积(AUC)为 0.82(95%CI:0.78~0.85);CEA 总灵敏度为 0.48(95%CI:0.40~0.56),总特异度为0.85(95%CI:0.79~0.89),AUC 为 0.74(95%CI:0.70~0.77);CA19-9 总灵敏度为 0.56(95%CI:0.50~0.61),总特异度为 0.80(95%CI:0.73~0.85),AUC 为 0.69(95%C/:0.65~0.73).三者中 AFP灵敏度和特异度均最高.AFP、CEA、CA19-9联合检测总灵敏度提高至为0.89(95%CI:0.85~0.92),总特异度下降到0.77(95%C/:0.70~0.82),AUC为0.91(95%CI:0.88~0.93).无论单独检测还是联合检测均未发现发表偏倚.结论 AFP单独检测灵敏度、特异度均较高,是可用于肝癌机会性筛查的肿瘤标志物.在应用AFP、CEA、CA19-9联合检测筛查肝癌时,应对结果更加谨慎地判读.
Value of serum AFP,CEA and CA19-9 detection in opportunistic screening for liver cancer in Chinese population:a meta-analysis
Objective To evaluate the value of detection of serum alpha-fetoprotein(AFP),carcinoembryonic antigen(CEA)and carbohydrate antigen 19-9(CA19-9)in opportunistic screening of liver cancer in Chinese population with a meta-analysis.Methods Literatures on combined screening of liver cancer by AFP,CEA and CA19-9 were retrieved from CNKI,Wanfang Database,Chongqing VIP database,PubMed,Embase and Cochrane Library from the establishment of the databases to June 2023.The Quality Assessment Tool of Diagnostic Accuracy Studies(QUADAS-2)was used to evaluate the quality of the literature.Stata 17.0 statistical software was used for meta-analysis,and Deeks funnel plot was used to analyze publication bias.Results A total of 24 literatures met the inclusion criteria,including 1471 patients with liver cancer and 2 150 controls.The overall sensitivity of AFP in liver cancer diagnosis(screening)was 0.71(95%CI:0.66-0.75),the total specificity was 0.86(95%CI:0.80-0.90),and the area under summary receiver operating characteristic(sROC)curve(AUC)was 0.82(95%CI:0.78-0.85).The total sensitivity of CEA in liver cancer diagnosis(screening)was 0.48(95%CI:0.40-0.56),the total specificity was 0.85(95%CI:0.79-0.89),and the AUC of sROC was 0.74(95%CI:0.70-0.77).The total sensitivity of CA19-9 in liver cancer diagnosis(screening)was 0.56(95%CI:0.50-0.61),the total specificity was 0.80(95%CI:0.73-0.85),and the AUC was 0.69(95%CI:0.65-0.73).AFP has the highest sensitivity and specificity among the three.The overall sensitivity of combined detection of AFP,CEA and CA19-9 for liver cancer diagnosis(screening)was increased to 0.89(95%CI:0.85-0.92),the overall specificity was 0.77(95%CI:0.70-0.82),and the AUC was 0.91(95%CI:0.88-0.93).No publication bias was found in either individual or combined test of the biomarkers.Conclusions Detection of AFP alone has high sensitivity and specificity,and it is a tumor marker that can be used for the opportunistic screening of liver cancer.When combined tests of AFP,CEA and CA19-9 are used to screen liver cancer,the results should be interpreted more carefully.

Alpha-fetoproteinCarcinoembryonic antigenCarbohydrate antigenLiver cancerOpportunistic screening

佟赫、阴建、安耀玉、张凯

展开 >

国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院防癌科,北京 100021

国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院流行病学研究室,北京 100021

甲胎蛋白 癌胚抗原 糖类抗原19-9 肝癌 机会性筛查

首都卫生发展科研专项项目

首发2022-2G-40210

2024

中华健康管理学杂志
中华医学会

中华健康管理学杂志

CSTPCD北大核心
影响因子:1.004
ISSN:1674-0815
年,卷(期):2024.18(4)
  • 45